Capital Pulse#94 min read

Week of Mar 02-06, 2026

Healthcare stocks bifurcated: behavioral health and healthcare IT surged on earnings beats, while payers and dental cratered on regulatory shocks and geopolitical contagion.

Dental

TickerCompanyPriceWoWYTD
XRAYDENTSPLY SIRONA$12.74-11.5%+11.1%
NVSTEnvista Holdings$26.86-6.9%+23.0%
ALGNAlign Technology$174.00-5.7%+10.3%
HSICHenry Schein$77.60-4.0%+2.6%

All four dental names declined. DENTSPLY SIRONA (XRAY) was the worst performer on the entire watchlist at -11.5%, hit by a geopolitical-driven selloff that disproportionately affected small- and mid-cap names. Director Gregory Lucier bought ~50,000 shares at $14.03-14.24 — meaningful insider conviction. Align (ALGN) -5.7%, Envista (NVST) -6.9%, Henry Schein (HSIC) -4.0%. No company-specific catalysts; this was risk-off rotation out of medtech and dental supply.

Payers & Insurance

TickerCompanyPriceWoWYTD
ELVElevance Health$289.64-8.1%-17.4%
CIThe Cigna Group$271.63-5.5%-1.3%
HUMHumana$179.15-4.9%-30.0%
MOHMolina Healthcare$144.47-4.7%-17.0%
CVSCVS Health$77.92-2.5%-0.9%
CNCCentene$43.65-1.3%+6.0%
UNHUnitedHealth Group$286.48-0.6%-13.4%

Every payer name finished in the red. Elevance Health (ELV) -8.1% after CMS notified the company of planned intermediate sanctions that could freeze Medicare Advantage enrollment starting March 31. The cause: Elevance used flash drives instead of CMS-approved electronic methods for risk adjustment data for seven years. Contagion hit the entire managed care complex — Humana -4.9%, Cigna -5.5%, Molina -4.7%. Only UnitedHealth (-0.6%) held firm.

Hospital Systems & Providers

TickerCompanyPriceWoWYTD
ACHCAcadia Healthcare$25.62+10.2%+79.2%
SEMSelect Medical$16.25+9.8%+9.7%
UHSUniversal Health Services$192.65-5.2%-11.5%
DVADaVita$150.76-2.8%+32.6%
HCAHCA Healthcare$532.81+0.5%+14.4%
CYHCommunity Health Systems$3.35+0.3%+7.4%
THCTenet Healthcare$236.95+0.0%+19.1%

The strongest sector. Acadia Healthcare (ACHC) +10.2% on Q4 revenue of $821.5M beating forecasts. 29% short interest creates massive squeeze potential. Select Medical (SEM) +9.8% continues its quiet run. HCA +0.5%. Hospital operators benefit from volume growth and are insulated from the Medicare Advantage drama hitting payers.

Healthcare Services & Tech

TickerCompanyPriceWoWYTD
GDRXGoodRx$2.28+26.7%-16.8%
VEEVVeeva Systems$195.49+8.5%-12.5%
HIMSHims & Hers Health$15.74+8.5%-52.3%
AGLagilon health$0.60+6.8%-14.7%
PGNYProgyny$18.31+6.0%-28.6%
OSCROscar Health$13.84+5.1%-4.2%
LFSTLifeStance Health$6.93-3.4%-1.3%
PRVAPrivia Health$23.27-3.0%-1.3%
ALHCAlignment Healthcare$18.44-2.6%-6.6%
TDOCTeladoc Health$5.08-0.2%-27.4%

The biggest dispersion. GoodRx (GDRX) surged +26.7% on reports it's negotiating with the White House to join the TrumpRx platform. Veeva Systems (VEEV) +8.5% after crushing Q4 — revenue $836M (+16% YoY), EPS $2.06 beat $1.94 consensus. Hims & Hers +8.5%. On the other side, Teladoc flat, LifeStance -3.4%, Privia -3.0%.

Weekly Intelligence Debrief

Macro narrative, theme clusters, and hidden connections for the week of Mar 02-06, 2026.

Macro Patterns

  • 1XLV underperformed SPY by 3.2 percentage points — worst week for healthcare vs. market in 2026
  • 2Payer selloff driven by Elevance CMS sanctions — regulatory risk repricing across managed care
  • 3Healthcare IT (Veeva) proving revenue durability commands premium in volatile markets

Week Ahead

  • 1No healthcare earnings on watchlist this week
  • 2CPI data Wednesday — higher rates compress healthcare growth multiples
  • 3Elevance/CMS March 31 sanctions deadline approaching
  • 4Q1 earnings season starts mid-April: JNJ (Apr 14), Abbott (Apr 15), UNH (Apr 16)

Contrarian Signal

DENTSPLY SIRONA director bought 50,000 shares into the -11.5% decline. Insider buying during selloffs is one of the strongest contrarian signals in small-cap healthcare.

Regulatory Pulse

CMS notified Elevance Health of planned intermediate sanctions that could freeze Medicare Advantage enrollment starting March 31. The cause: using flash drives instead of CMS-approved electronic methods for risk adjustment data submission over seven years. Court decision expected by March 31. DOJ gender-affirming care subpoenas headed to Ninth Circuit.

Watchlist Signal

Healthcare Services & Tech outperformed XLV by +9.3%. Hospitals outperformed by +5.9%. Payers tracked XLV. Dental underperformed by -2.9%. Binary catalysts ahead: GoodRx/TrumpRx, Elevance/CMS March 31 deadline, Acadia short squeeze at 29%.

Data Point of the Week

XLV -4.1% vs SPY -0.9% — healthcare underperformed the broad market by 3.2 percentage points this week.

Get The Healthcare Edge in your inbox

Daily intelligence for dental professionals. Free, forever.